Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and Remimazolam for Postoperative Acute Sleep Disturbance After Gynecological Surgery
ChiCTR2500099972Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and remimazolam in Insomnia and sleep disorder (4 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoint: Postoperative sleep condition. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
esketamineremimazolam
03
Conditions
Insomniasleep disorder
Beyond the preview
Go deeper on ChiCTR2500099972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099972.